William Jackson, MD
Radiation Oncology · Ann Arbor, MINPI 1265852362
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 7 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Icotec Medical Inc. accounts for 68.6% of it on its own, with 3 other manufacturers making up the rest. 2025 is the largest year on record at $354, 8.7 times the $41 reported in 2022.
Across 7 payments — averaging $73.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Icotec Medical Inc.$354
- Novo Nordisk$121
- Myovant Sciences Inc.$25
- AstraZeneca$16
Across 24 payments — averaging $65,256 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$1.6M
What the payments were for
- Food & beverage$517100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Icotec Medical Inc. | 4 | $354 |
| Novo Nordisk | 1 | $121 |
| Myovant Sciences Inc. | 1 | $25 |
| AstraZeneca | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VADER PEDICLE SYSTEM 6.0, SCREW, Carbon/PEEK, POLYAX., FEN., O 5.5 X 45 MM$203
- VADER PEDICLE SYSTEM, ROD, Carbon/PEEK, CURVED, 6.0 R450 X 200 MM$203
- KONG-TL VBR E, EXPANDABLE BODY, L, 19 MM X 27 - 37 MM$203
- KONG-TL VBR, END PLATE, ROUND, L AND SCREW, 12 X 43 MM$203
- KONG-TL VBR, END PLATE, RECTANGULAR, M AND SCREW, 12 X 33 MM$203
- Wegovy$121
How this compares
$517 in reported general payments places this provider in the 55th percentile of 198 radiation oncology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 54 | $987 |
| Cephalexin | 17 | $46 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Ann Arbor
- Daniel WahlAnn Arbor$42K
- Daniel ChangAnn Arbor$38K
- Shruti JollyAnn Arbor$30K
- James KaneAnn Arbor$19K
- Theodore LawrenceAnn Arbor$12K
- Michelle MierzwaAnn Arbor$2K
- Michelle KimAnn Arbor$2K
- Michael GreenAnn Arbor$2K
- Sean MillerAnn Arbor$1K
- Frank ViciniPontiac$231K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.